$2.34
0.000.00%
Comments
Loading...
Intensity Therapeutics Stock Guidance | NASDAQ:INTS | Benzinga
Intensity Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Intensity Therapeutics (INTS)?
There have been no specific sales or earnings guidance reported for Intensity Therapeutics in recent months.
Browse guidance and forecast on all stocks.